Skip to NavigationSkip to content

News

Deal covers 18 products in nine countries
Ratiopharm HQ
Company competes with Actavis and Teva
Pays $10m for rights to targeted immunotherapy product
PPD opens new research lab in Athlone and Warner Chilcott establishes HQ in Dundalk
Penknife

To assemble an orphan and rare disease marketing brand you’ll need a versatile toolkit, says MSI’s Michael Craig

Appointments

Teva Pharmaceutical Industries has appointed Dr Phillip Frost as chairman of the board of directors.

His appointment is part of a reshuffle...

a site by SiftGroups